Systematic review of covid-19 and covid-19 mRNA vaccine myocarditis in athletes: Incidence, diagnosis, prognosis, and return-to-play principles

(Systematische Überprüfung der Myokarditis bei Sportlern durch Covid-19- und Covid-19-MRNA-Impfstoff: Inzidenz, Diagnose, Prognose und Grundsätze für die Rückkehr zum Spiel)

Objective: The purpose of this systematic review is to evaluate the original peer-reviewed studies on athletes who developed myocarditis after coronavirus disease (COVID-19) infection or after COVID-19 mRNA vaccination. Both entities likely have an immunologic component. We discuss elite, professional, college, and adolescent athletes. The athletes are generally young and healthy, representing a distinctive population group that differs from the general population. This review includes diagnosis of myocarditis, incidence, complications, prognosis, and return-to-play guidance for sports medicine clinicians and coaches. Data Sources: We surveyed the PUBMED, Embase, and Web of Science databases for the relevant peer-reviewed articles in the English language published from the onset of the pandemic until April 2023. Included were original observational studies and case series. Excluded were individual case reports and a small series with incomplete data. The resulting search yielded 30 original articles. Main Results: Reported myocardial abnormalities in athletes were rare after COVID-19 infection and even less frequent after COVID-19 mRNA vaccination. True incidence, however, may be higher because of under-reporting and frequent asymptomatic presentation. Male gender was prevalent for both manifestations; postvaccination myocarditis occurrence was the highest after the second vaccine dose. Diagnostic and return-to-play algorithms were developed and should be adopted and followed. Conclusions: The risk of myocarditis from COVID-19 infection and COVID-19 mRNA vaccination is very low. The long-term prognosis and evolution of the observed cardiac magnetic resonance abnormalities are currently unknown. Although inferences can be made from the published data, COVID-19 and postvaccine myocarditis in athletes may represent only a small fraction of the true incidence of those who have been affected worldwide and not evaluated.
© Copyright 2025 Clinical Journal of Sport Medicine. Lippincott Williams & Wilkins. Alle Rechte vorbehalten.

Bibliographische Detailangaben
Schlagworte:
Notationen:Biowissenschaften und Sportmedizin
Tagging:COVID-19 Impfung
Veröffentlicht in:Clinical Journal of Sport Medicine
Sprache:Englisch
Veröffentlicht: 2025
Online-Zugang:https://doi.org/10.1097/JSM.0000000000001320
Jahrgang:35
Heft:2
Seiten:191-205
Dokumentenarten:Artikel
Level:hoch